Retrospective diagnostic accuracy study of abbott RealTime MTB against Xpert MTB/RIF Ultra and Xpert MTB/RIF for the diagnosis of pulmonary tuberculosis and susceptibility to rifampin and isoniazid treatment

In 2019, 10 million people fell ill with tuberculosis (TB), of whom 1.4 million died. - There are few comparative studies of diagnostic assays, particularly those aiming - to be used in high-throughput laboratories.

Saved in:
Bibliographic Details
Main Authors: Howlett, Patrick (Author) , Nabeta, Pamela (Author) , Tukvadze, Nestan (Author) , Schumacher, Samuel G. (Author) , Denkinger, Claudia M. (Author)
Format: Article (Journal)
Language:English
Published: 18 August 2021
In: Microbiology spectrum
Year: 2021, Volume: 9, Issue: 1, Pages: 1-11
ISSN:2165-0497
DOI:10.1128/Spectrum.00132-21
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1128/Spectrum.00132-21
Verlag, lizenzpflichtig, Volltext: https://journals.asm.org/doi/abs/10.1128/Spectrum.00132-21
Get full text
Author Notes:Patrick Howlett, Pamela Nabeta, Nestan Tukvadze, Samuel G. Schumacher, and Claudia M. Denkinger
Description
Summary:In 2019, 10 million people fell ill with tuberculosis (TB), of whom 1.4 million died. - There are few comparative studies of diagnostic assays, particularly those aiming - to be used in high-throughput laboratories.
Item Description:Gesehen am 18.11.2021
Physical Description:Online Resource
ISSN:2165-0497
DOI:10.1128/Spectrum.00132-21